Ecofibre Ltd - Asset Resilience Ratio

Latest as of December 2024: 6.67%

Ecofibre Ltd (EOF) has an Asset Resilience Ratio of 6.67% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Ecofibre Ltd (EOF) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

AU$3.87 Million
≈ $2.74 Million USD Cash + Short-term Investments

Total Assets

AU$58.04 Million
≈ $41.07 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2017–2024)

This chart shows how Ecofibre Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see EOF current and non-current assets.

Liquid Assets Composition Over Time

This chart breaks down Ecofibre Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read debt load of Ecofibre Ltd for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents AU$3.87 Million 6.67%
Short-term Investments AU$0.00 0%
Total Liquid Assets AU$3.87 Million 6.67%

Asset Resilience Insights

  • Limited Liquidity: Ecofibre Ltd maintains only 6.67% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Ecofibre Ltd Industry Peers by Asset Resilience Ratio

Compare Ecofibre Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
Drug Manufacturers - Specialty & Generic 1.54%
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
Drug Manufacturers - Specialty & Generic 4.94%
Takeda Pharmaceutical Company Limited
F:TKDA
Drug Manufacturers - Specialty & Generic 0.69%
Piramal Pharma Limited
NSE:PPLPHARMA
Drug Manufacturers - Specialty & Generic 0.73%
Kangmei Pharmaceutical Co Ltd
SHG:600518
Drug Manufacturers - Specialty & Generic 0.00%
Zhejiang Medicine Co Ltd
SHG:600216
Drug Manufacturers - Specialty & Generic 1.85%
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091
Drug Manufacturers - Specialty & Generic 26.36%
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557
Drug Manufacturers - Specialty & Generic 0.29%

Annual Asset Resilience Ratio for Ecofibre Ltd (2017–2024)

The table below shows the annual Asset Resilience Ratio data for Ecofibre Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-06-30 0.28% AU$200.00K
≈ $141.51K
AU$71.25 Million
≈ $50.41 Million
-0.01pp
2023-06-30 0.29% AU$347.00K
≈ $245.52K
AU$118.73 Million
≈ $84.01 Million
-4.69pp
2022-06-30 4.99% AU$7.46 Million
≈ $5.28 Million
AU$149.55 Million
≈ $105.82 Million
+1.97pp
2021-06-30 3.02% AU$4.28 Million
≈ $3.03 Million
AU$141.75 Million
≈ $100.29 Million
-10.29pp
2020-06-30 13.31% AU$11.22 Million
≈ $7.94 Million
AU$84.30 Million
≈ $59.64 Million
-35.74pp
2019-06-30 49.05% AU$23.43 Million
≈ $16.58 Million
AU$47.77 Million
≈ $33.80 Million
+24.59pp
2018-06-30 24.46% AU$2.76 Million
≈ $1.95 Million
AU$11.27 Million
≈ $7.97 Million
-15.83pp
2017-06-30 40.29% AU$2.45 Million
≈ $1.73 Million
AU$6.08 Million
≈ $4.30 Million
--
pp = percentage points

About Ecofibre Ltd

AU:EOF Australia Drug Manufacturers - Specialty & Generic
Market Cap
$5.36 Million
AU$7.58 Million AUD
Market Cap Rank
#28543 Global
#1512 in Australia
Share Price
AU$0.02
Change (1 day)
+0.00%
52-Week Range
AU$0.02 - AU$0.02
All Time High
AU$3.79
About

Ecofibre Limited, together with its subsidiaries, engages in the polymer, health care, and hemp seed genetics businesses in the United States and Australia. The company operates through Ecofibre Advanced Technologies, Ananda Health, Ecofibre Genetics, and EOF Bio segments. It offers cannabinoid based health products for human and pet consumption. In addition, the company provides yarn, polymer te… Read more